Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. (2015)
Attributed to:
The Development of Inhibitors of Cdk Activating Kinase (CAK)
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1373/clinchem.2015.238717
PubMed Identifier: 25979954
Publication URI: http://europepmc.org/abstract/MED/25979954
Type: Journal Article/Review
Volume: 61
Parent Publication: Clinical chemistry
Issue: 7
ISSN: 0009-9147